Selective Roles of Normal and Mutant Huntingtin in Neural Induction and Early Neurogenesis

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Nguyen, Giang D ^a   Gokhan, Solen ^a   Molero, Aldrin E ^a   Mehler, Mark F ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; HUNTINGTIN; NOTCH RECEPTOR; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR HES 5;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENZYME ACTIVITY; GENE; GENE EXPRESSION PROFILING; HES1 GENE; HES5 GENE; HUNTINGTON CHOREA; IN VITRO STUDY; MOLECULAR CLONING; MOUSE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; NOTCH GENE; OLIGODENDROGLIA; PROTEIN FUNCTION;

ANIMALS; CELL PROLIFERATION; ECTODERM; EMBRYONIC STEM CELLS; ENDODERM; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; LEUKEMIA INHIBITORY FACTOR; MICE; MUTATION; NERVE TISSUE PROTEINS; NEURAL PLATE; NEURAL STEM CELLS; NEUROGENESIS; NUCLEAR PROTEINS; OLIGODENDROGLIA; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 84877724489     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064368     Document Type: Article

References (66)

1. Gil JM, Rego AC, (2008) Mechanisms of neurodegeneration in Huntington's disease. The European journal of neuroscience 27: 2803-2820.
2. Harjes P, Wanker EE, (2003) The hunt for huntingtin function: interaction partners tell many different stories. Trends in biochemical sciences 28: 425-433.
3. Kaltenbach LS, Romero E, Becklin RR, Chettier R, Bell R, et al. (2007) Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS genetics 3: e82.
4. Li SH, Li XJ, (2004) Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends in genetics: TIG 20: 146-154.
5. Rigamonti D, Sipione S, Goffredo D, Zuccato C, Fossale E, et al. (2001) Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing. The Journal of biological chemistry 276: 14545-14548.
6. Cattaneo E, Zuccato C, Tartari M, (2005) Normal huntingtin function: an alternative approach to Huntington's disease. Nature reviews Neuroscience 6: 919-930.
7. Dragatsis I, Levine MS, Zeitlin S, (2000) Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nature genetics 26: 300-306.
8. Nasir J, Floresco SB, O'Kusky JR, Diewert VM, Richman JM, et al. (1995) Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81: 811-823.
9. Zeitlin S, Liu JP, Chapman DL, Papaioannou VE, Efstratiadis A, (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nature genetics 11: 155-163.
10. Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, et al. (1995) Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 269: 407-410.
11. Woda JM, Calzonetti T, Hilditch-Maguire P, Duyao MP, Conlon RA, et al. (2005) Inactivation of the Huntington's disease gene (Hdh) impairs anterior streak formation and early patterning of the mouse embryo. BMC developmental biology 5: 17.
12. White JK, Auerbach W, Duyao MP, Vonsattel JP, Gusella JF, et al. (1997) Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nature genetics 17: 404-410.
13. Molero AE, Gokhan S, Gonzalez S, Feig JL, Alexandre LC, et al. (2009) Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America 106: 21900-21905.
14. Batista CM, Kippin TE, Willaime-Morawek S, Shimabukuro MK, Akamatsu W, et al. (2006) A progressive and cell non-autonomous increase in striatal neural stem cells in the Huntington's disease R6/2 mouse. The Journal of neuroscience: the official journal of the Society for Neuroscience 26: 10452-10460.
15. Curtis MA, Penney EB, Pearson AG, van Roon-Mom WM, Butterworth NJ, et al. (2003) Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proceedings of the National Academy of Sciences of the United States of America 100: 9023-9027.
16. Curtis MA, Penney EB, Pearson J, Dragunow M, Connor B, et al. (2005) The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain. Neuroscience 132: 777-788.
17. Conforti P, Camnasio S, Mutti C, Valenza M, Thompson M, et al. (2013) Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death. Neurobiol Dis 50: 160-170.
18. Milnerwood AJ, Raymond LA, (2010) Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease. Trends in neurosciences 33: 513-523.
19. Joshi PR, Wu NP, Andre VM, Cummings DM, Cepeda C, et al. (2009) Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease. The Journal of neuroscience: the official journal of the Society for Neuroscience 29: 2414-2427.
20. Murphy KP, Carter RJ, Lione LA, Mangiarini L, Mahal A, et al. (2000) Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. The Journal of neuroscience: the official journal of the Society for Neuroscience 20: 5115-5123.
21. Brandt J, Shpritz B, Codori AM, Margolis R, Rosenblatt A, (2002) Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals. Journal of the International Neuropsychological Society: JINS 8: 918-924.
22. Schippling S, Schneider SA, Bhatia KP, Munchau A, Rothwell JC, et al. (2009) Abnormal motor cortex excitability in preclinical and very early Huntington's disease. Biological psychiatry 65: 959-965.
23. Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, et al. (2008) Detection of Huntington's disease decades before diagnosis: the Predict-HD study. Journal of neurology, neurosurgery, and psychiatry 79: 874-880.
24. Berrios GE, Wagle AC, Markova IS, Wagle SA, Ho LW, et al. (2001) Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington's disease gene carriers. Psychiatry Res. 102(3): 217-25.
25. Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, et al. (2006) Brain structure in preclinial Huntington's disease. Biol Psychiatry 59(1): 57-64.
26. Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, et al. (2003) Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60: 1615-1620.
27. Kassubek J, Gaus W, Landwehrmeyer GB (2004) Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 62: 523-524; author reply 524.
28. Smukler SR, Runciman SB, Xu S, van der Kooy D, (2006) Embryonic stem cells assume a primitive neural stem cell fate in the absence of extrinsic influences. The Journal of cell biology 172: 79-90.
29. Tropepe V, Hitoshi S, Sirard C, Mak TW, Rossant J, et al. (2001) Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron 30: 65-78.
30. Wheeler VC, White JK, Gutekunst CA, Vrbanac V, Weaver M, et al. (2000) Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum mol genet. 9(4): 503-513.
31. Tropepe V, Sibilia M, Ciruna BG, Rossant J, Wagner EF, et al. (1999) Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Developmental biology 208: 166-.
32. Hitoshi S, Alexson T, Tropepe V, Donoviel D, Elia AJ, et al. (2002) Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. Genes & development 16: 846-858.
33. Hitoshi S, Seaberg RM, Koscik C, Alexson T, Kusunoki S, et al. (2004) Primitive neural stem cells from the mammalian epiblast differentiate to definitive neural stem cells under the control of Notch signaling. Genes & development 18: 1806-1811.
34. Wilson SI, Edlund T, (2001) Neural induction: toward a unifying mechanism. Nat Neurosci 4Suppl: 1161-1168.
35. Levine AJ, Brivanlou AH, (2007) Proposal of a model of mammalian neural induction. Developmental biology 308: 247-256.
36. Liu YF, Deth RC, Devys D, (1997) SH3 domain-dependent association of huntingtin with epidermal growth factor receptor signaling complexes. The Journal of biological chemistry 272: 8121-8124.
37. Curto M, Frankel P, Carrero A, Foster DA, (1998) Novel recruitment of Shc, Grb2, and Sos by fibroblast growth factor receptor-1 in v-Src-transformed cells. Biochem Biophys Res Commun 243: 555-560.
38. Shimojo H, Ohtsuka T, Kageyama R, (2008) Oscillations in notch signaling regulate maintenance of neural progenitors. Neuron 58: 52-64.
39. Kobayashi T, Kageyama R, (2010) Hes1 regulates embryonic stem cell differentiation by suppressing Notch signaling. Genes to cells: devoted to molecular & cellular mechanisms 15: 689-698.
40. Kobayashi T, Mizuno H, Imayoshi I, Furusawa C, Shirahige K, et al. (2009) The cyclic gene Hes1 contributes to diverse differentiation responses of embryonic stem cells. Genes & development 23: 1870-1875.
41. Lowell S, Benchoua A, Heavey B, Smith AG, (2006) Notch promotes neural lineage entry by pluripotent embryonic stem cells. PLoS biology 4: e121.
42. Moores JN, Roy S, Nicholson DW, Staveley BE, (2008) Huntingtin interacting protein 1 can regulate neurogenesis in Drosophila. Eur J Neurosci 28(3): 599-609.
43. Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, et al. (2003) Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nature genetics 35: 76-83.
44. Yamada Y, Aoki H, Kunisada T, Hara A, (2010) Rest promotes the early differentiation of mouse ESCs but is not required for their maintenance. Cell stem cell 6: 10-15.
45. Jin K, LaFevre-Bernt M, Sun Y, Chen S, Gafni J, et al. (2005) FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America 102: 18189-18194.
46. Faux CH, Turnley AM, Epa R, Cappai R, Bartlett PF, (2001) Interactions between fibroblast growth factors and Notch regulate neuronal differentiation. The Journal of neuroscience: the official journal of the Society for Neuroscience 21: 5587-5596.
47. Hatakeyama J, Bessho Y, Katoh K, Ookawara S, Fujioka M, et al. (2004) Hes genes regulate size, shape and histogenesis of the nervous system by control of the timing of neural stem cell differentiation. Development 131: 5539-5550.
48. Basak O, Taylor V, (2007) Identification of self-replicating multipotent progenitors in the embryonic nervous system by high Notch activity and Hes5 expression. The European journal of neuroscience 25: 1006-1022.
49. Hatakeyama J, Kageyama R, (2006) Notch1 expression is spatiotemporally correlated with neurogenesis and negatively regulated by Notch1-independent Hes genes in the developing nervous system. Cerebral cortex 16Suppl 1: i132-137.
50. Morrison SJ, Kimble J, (2006) Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 441: 1068-1074.
51. Ogata T, Ueno T, Hoshikawa S, Ito J, Okazaki R, et al. (2011) Hes1 functions downstream of growth factors to maintain oligodendrocyte lineage cells in the early progenitor stage. Neuroscience 176: 132-141.
52. Myers RH, Vonsattel JP, Paskevich PA, Kiely DK, Stevens TJ, et al. (1991) Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. Journal of neuropathology and experimental neurology 50: 729-742.
53. Mason HA, Rakowiecki SM, Raftopoulou M, Nery S, Huang Y, et al. (2005) Notch signaling coordinates the patterning of striatal compartments. Development 132: 4247-4258.
54. Lorincz MT, Zawistowski VA, (2009) Expanded CAG repeats in the murine Huntington's disease gene increases neuronal differentiation of embryonic and neural stem cells. Molecular and cellular neurosciences 40: 1-13.
55. Kennedy L, Shelbourne PF, (2000) Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease? Hum Mol Genet 9: 2539-2544.
56. Goula AV, Berquist BR, Wilson DM, 3rd, Wheeler VC, Trottier Y, et al (2009) Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington's disease transgenic mice. PLoS genetics 5: e1000749.
57. Kennedy L, Evans E, Chen CM, Craven L, Detloff PJ, et al. (2003) Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. Hum Mol Genet 12: 3359-3367.
58. Zuccato C, Valenza M, Cattaneo E, (2010) Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiological reviews 90: 905-981.
59. Marder K, Mehler MF, (2012) Development and neurodegeneration: turning HD pathogenesis on its head. Neurology 79: 621-622.
60. Dogan I, Eickhoff SB, Schulz JB, Shah NJ, Laird AR, et al. (2012) Consistent Neurodegeneration and Its Association with Clinical Progression in Huntington's Disease: A Coordinate-Based Meta-Analysis. Neuro-degenerative diseases.
61. Braak H, Thal DR, Ghebremedhin E, Del Tredici K, (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70: 960-969.
62. Braak H, Del Tredici K, (2009) Neuroanatomy and pathology of sporadic Parkinson's disease. Adv Anat Embryol Cell Biol 201: 1-119.
63. Vonsattel JP, DiFiglia M, (1998) Huntington disease. J Neuropathol Exp Neurol 57: 369-384.
64. Abrajano JJ, Qureshi IA, Gokhan S, Zheng D, Bergman A, et al. (2009) Differential deployment of REST and CoREST promotes glial subtype specification and oligodendrocyte lineage maturation. PloS one 4: e7665.
65. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
66. Pfaffl MW, Horgan GW, Dempfle L, (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36.